• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素受体增强子活性的功能图谱。

Functional mapping of androgen receptor enhancer activity.

机构信息

Vancouver Prostate Centre, Department of Urologic Science, University of British Columbia, Vancouver, Canada.

School of Medicine, Koç University, Istanbul, Turkey.

出版信息

Genome Biol. 2021 May 11;22(1):149. doi: 10.1186/s13059-021-02339-6.

DOI:10.1186/s13059-021-02339-6
PMID:33975627
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8112059/
Abstract

BACKGROUND

Androgen receptor (AR) is critical to the initiation, growth, and progression of prostate cancer. Once activated, the AR binds to cis-regulatory enhancer elements on DNA that drive gene expression. Yet, there are 10-100× more binding sites than differentially expressed genes. It is unclear how or if these excess binding sites impact gene transcription.

RESULTS

To characterize the regulatory logic of AR-mediated transcription, we generated a locus-specific map of enhancer activity by functionally testing all common clinical AR binding sites with Self-Transcribing Active Regulatory Regions sequencing (STARRseq). Only 7% of AR binding sites displayed androgen-dependent enhancer activity. Instead, the vast majority of AR binding sites were either inactive or constitutively active enhancers. These annotations strongly correlated with enhancer-associated features of both in vitro cell lines and clinical prostate cancer samples. Evaluating the effect of each enhancer class on transcription, we found that AR-regulated enhancers frequently interact with promoters and form central chromosomal loops that are required for transcription. Somatic mutations of these critical AR-regulated enhancers often impact enhancer activity.

CONCLUSIONS

Using a functional map of AR enhancer activity, we demonstrated that AR-regulated enhancers act as a regulatory hub that increases interactions with other AR binding sites and gene promoters.

摘要

背景

雄激素受体(AR)对前列腺癌的发生、生长和进展至关重要。一旦被激活,AR 就会与 DNA 上的顺式调节增强子元件结合,从而驱动基因表达。然而,有 10-100 倍以上的结合位点比差异表达的基因多。目前尚不清楚这些多余的结合位点是否以及如何影响基因转录。

结果

为了表征 AR 介导的转录的调控逻辑,我们通过自我转录活性调控区测序(STARRseq)功能测试所有常见的临床 AR 结合位点,生成了一个具有特定基因座的增强子活性图谱。只有 7%的 AR 结合位点显示出雄激素依赖性增强子活性。相反,绝大多数 AR 结合位点要么是无活性的,要么是组成性的增强子。这些注释与体外细胞系和临床前列腺癌样本的增强子相关特征强烈相关。评估每个增强子类别对转录的影响,我们发现 AR 调节的增强子经常与启动子相互作用,并形成中央染色体环,这是转录所必需的。这些关键的 AR 调节增强子的体细胞突变通常会影响增强子活性。

结论

使用 AR 增强子活性的功能图谱,我们证明了 AR 调节的增强子作为一个调控枢纽,增加了与其他 AR 结合位点和基因启动子的相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf1/8112059/c118336c6437/13059_2021_2339_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf1/8112059/1bdd05943540/13059_2021_2339_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf1/8112059/4167ae54d2ba/13059_2021_2339_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf1/8112059/0be13ae01ca8/13059_2021_2339_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf1/8112059/44e078a7e7c7/13059_2021_2339_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf1/8112059/abc97ffb0b52/13059_2021_2339_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf1/8112059/c118336c6437/13059_2021_2339_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf1/8112059/1bdd05943540/13059_2021_2339_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf1/8112059/4167ae54d2ba/13059_2021_2339_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf1/8112059/0be13ae01ca8/13059_2021_2339_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf1/8112059/44e078a7e7c7/13059_2021_2339_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf1/8112059/abc97ffb0b52/13059_2021_2339_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf1/8112059/c118336c6437/13059_2021_2339_Fig6_HTML.jpg

相似文献

1
Functional mapping of androgen receptor enhancer activity.雄激素受体增强子活性的功能图谱。
Genome Biol. 2021 May 11;22(1):149. doi: 10.1186/s13059-021-02339-6.
2
In-silico identification and functional validation of allele-dependent AR enhancers.等位基因依赖性雄激素受体增强子的计算机识别与功能验证
Oncotarget. 2015 Mar 10;6(7):4816-28. doi: 10.18632/oncotarget.3019.
3
Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation.达罗他胺通过阻断增强子和超级增强子的激活来拮抗雄激素信号。
Mol Oncol. 2020 Sep;14(9):2022-2039. doi: 10.1002/1878-0261.12693. Epub 2020 Jun 5.
4
Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets.全球分析去势抵抗性前列腺癌细胞中的转录,揭示了活跃的增强子和直接雄激素受体靶标。
Sci Rep. 2016 Sep 19;6:33510. doi: 10.1038/srep33510.
5
Androgen receptor enhancer usage and the chromatin regulatory landscape in human prostate cancers.雄激素受体增强子的使用和人类前列腺癌中的染色质调控景观。
Endocr Relat Cancer. 2019 May;26(5):R267-R285. doi: 10.1530/ERC-19-0032.
6
Androgen receptor-binding sites are highly mutated in prostate cancer.雄激素受体结合位点在前列腺癌中高度突变。
Nat Commun. 2020 Feb 11;11(1):832. doi: 10.1038/s41467-020-14644-y.
7
Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.前列腺特异性抗原启动子增强子核心区域负调控顺式元件的鉴定:对前列腺癌细胞中雄激素受体与核因子-κB信号通路交叉的意义
Biochem J. 2004 Apr 15;379(Pt 2):421-31. doi: 10.1042/BJ20031661.
8
Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation.增强子 RNA 参与雄激素受体驱动的环化,从而选择性地增强基因激活。
Proc Natl Acad Sci U S A. 2014 May 20;111(20):7319-24. doi: 10.1073/pnas.1324151111. Epub 2014 Apr 28.
9
Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions.在雄激素剥夺条件下,去势抵抗性前列腺癌中持续的雄激素受体介导的转录。
Nucleic Acids Res. 2012 Nov;40(21):10765-79. doi: 10.1093/nar/gks888. Epub 2012 Sep 27.
10
Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.活化的Cdc42相关激酶Ack1通过雄激素受体酪氨酸磷酸化促进前列腺癌进展。
Proc Natl Acad Sci U S A. 2007 May 15;104(20):8438-43. doi: 10.1073/pnas.0700420104. Epub 2007 May 9.

引用本文的文献

1
Evolving roles for the androgen receptor and its protein interactome in castration-resistant prostate cancer.雄激素受体及其蛋白质相互作用组在去势抵抗性前列腺癌中的角色演变
Oncogene. 2025 Sep 18. doi: 10.1038/s41388-025-03573-z.
2
Comprehensive functional annotation of ESR1-driven enhancers in breast cancer reveals hierarchical activity independent of genomic and epigenomic contexts.对乳腺癌中ESR1驱动的增强子进行全面功能注释,揭示了独立于基因组和表观基因组背景的分层活性。
Genome Res. 2025 Jul 1;35(7):1530-1543. doi: 10.1101/gr.280320.124.
3
Defined cellular reprogramming of androgen receptor-active prostate cancer to neuroendocrine prostate cancer.

本文引用的文献

1
ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis.ArchR 是一个可扩展的软件包,用于整合单细胞染色质可及性分析。
Nat Genet. 2021 Mar;53(3):403-411. doi: 10.1038/s41588-021-00790-6. Epub 2021 Feb 25.
2
Regulatory sharing between estrogen receptor α bound enhancers.雌激素受体 α 结合增强子之间的调控共享。
Nucleic Acids Res. 2020 Jul 9;48(12):6597-6610. doi: 10.1093/nar/gkaa454.
3
Histone H3K27 acetylation is dispensable for enhancer activity in mouse embryonic stem cells.组蛋白H3K27乙酰化对于小鼠胚胎干细胞中的增强子活性而言并非必需。
雄激素受体活性前列腺癌向神经内分泌前列腺癌的特定细胞重编程。
bioRxiv. 2025 Mar 7:2025.02.12.637904. doi: 10.1101/2025.02.12.637904.
4
Decoding the epigenetics and chromatin loop dynamics of androgen receptor-mediated transcription.解析雄激素受体介导的转录的表观遗传学和染色质环动力学。
Nat Commun. 2024 Nov 3;15(1):9494. doi: 10.1038/s41467-024-53758-5.
5
Leveraging Random Effects in Cistrome-Wide Association Studies for Decoding the Genetic Determinants of Prostate Cancer.利用染色质免疫沉淀关联研究中的随机效应来解码前列腺癌的遗传决定因素。
Adv Sci (Weinh). 2024 Sep;11(36):e2400815. doi: 10.1002/advs.202400815. Epub 2024 Aug 5.
6
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions.雌激素受体 1 染色质在人乳腺肿瘤中的特征分析揭示了高的患者间异质性,并且在大多数保守区域富集了风险 SNPs 和增强子活性。
Genome Res. 2024 May 15;34(4):539-555. doi: 10.1101/gr.278680.123.
7
The androgen receptor in bladder cancer.膀胱癌中的雄激素受体。
Nat Rev Urol. 2023 Sep;20(9):560-574. doi: 10.1038/s41585-023-00761-y. Epub 2023 Apr 18.
8
Optimized high-throughput screening of non-coding variants identified from genome-wide association studies.优化高通量筛选全基因组关联研究中鉴定的非编码变异。
Nucleic Acids Res. 2023 Feb 22;51(3):e18. doi: 10.1093/nar/gkac1198.
9
Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential.原发前列腺癌中广泛的雄激素受体增强子异质性是转录多样性和转移潜能的基础。
Nat Commun. 2022 Nov 30;13(1):7367. doi: 10.1038/s41467-022-35135-2.
10
Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence.药物诱导的表观基因组可塑性重塑生物钟节律调节,导致前列腺癌向雄激素非依赖性进展。
Cancer Discov. 2022 Sep 2;12(9):2074-2097. doi: 10.1158/2159-8290.CD-21-0576.
Genome Biol. 2020 Feb 21;21(1):45. doi: 10.1186/s13059-020-01957-w.
4
Androgen receptor-binding sites are highly mutated in prostate cancer.雄激素受体结合位点在前列腺癌中高度突变。
Nat Commun. 2020 Feb 11;11(1):832. doi: 10.1038/s41467-020-14644-y.
5
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.分析 2658 个癌症全基因组中的非编码体细胞驱动因子。
Nature. 2020 Feb;578(7793):102-111. doi: 10.1038/s41586-020-1965-x. Epub 2020 Feb 5.
6
Pan-cancer analysis of whole genomes.泛癌症全基因组分析。
Nature. 2020 Feb;578(7793):82-93. doi: 10.1038/s41586-020-1969-6. Epub 2020 Feb 5.
7
Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate Tumors.染色质结构域分区揭示了原发性前列腺肿瘤中主转录调控因子的体细胞突变和风险变异的趋同。
Cancer Cell. 2019 Dec 9;36(6):674-689.e6. doi: 10.1016/j.ccell.2019.10.005. Epub 2019 Nov 14.
8
The genomic landscape of estrogen receptor α binding sites in mouse mammary gland.小鼠乳腺中雌激素受体 α 结合位点的基因组景观。
PLoS One. 2019 Aug 13;14(8):e0220311. doi: 10.1371/journal.pone.0220311. eCollection 2019.
9
C/EBPα mediates the growth inhibitory effect of progestins on breast cancer cells.C/EBPα 介导孕激素对乳腺癌细胞的生长抑制作用。
EMBO J. 2019 Sep 16;38(18):e101426. doi: 10.15252/embj.2018101426. Epub 2019 Aug 2.
10
Phase separation of ligand-activated enhancers licenses cooperative chromosomal enhancer assembly.配体激活增强子的相分离赋予协同染色体增强子组装的许可。
Nat Struct Mol Biol. 2019 Mar;26(3):193-203. doi: 10.1038/s41594-019-0190-5. Epub 2019 Mar 4.